In triple-negative breast cancer TP53 is the only mutations that occurs at a high percent of patients (80%), while the vast majority of mutations (including PIK3CA, RB1, PTEN, MYO3A, and GH1) occur at low percentages (<10%) in the patient cohorts [7]. The gene discussed is RB1; the disease is triple-negative breast carcinoma.